Stock Analysis on Net

Shockwave Medical Inc. (NASDAQ:SWAV)

This company has been moved to the archive! The financial data has not been updated since May 6, 2024.

Balance Sheet: Liabilities and Stockholders’ Equity 
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Shockwave Medical Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in thousands

Microsoft Excel
Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Accounts payable 9,843 8,868 6,870 12,869 11,050 6,721 3,469 5,266 8,467 3,520 3,632 2,633 3,728 1,466 1,972 2,562 2,150 2,790 2,486 2,216 3,967
Debt, current portion 80,000 11,000 8,250 5,500 2,750 4,125 4,950 3,300 1,650 6,667 6,667 5,000 3,333
Accrued liabilities 78,838 91,696 69,764 65,769 49,640 55,375 49,492 47,253 33,019 40,870 33,017 28,317 23,918 19,942 16,662 14,381 15,826 13,777 9,496 7,378 6,439
Operating lease liability, current portion 3,653 3,641 1,569 1,582 1,308 1,278 1,260 2,688 1,294 1,738 867 920 898 873 841 798 787 774 742 806 877
Current liabilities 92,334 104,205 78,203 80,220 141,998 63,374 54,221 66,207 51,030 51,628 40,266 35,995 33,494 25,581 21,125 17,741 18,763 24,008 19,391 15,400 14,616
Operating lease liability, noncurrent portion 40,336 35,103 32,358 33,205 34,058 34,928 38,532 27,157 32,361 28,321 11,939 6,911 7,213 7,488 7,685 7,903 8,077 8,125 1,543 1,732 1,916
Convertible debt, noncurrent portion 732,810 731,863 730,926
Debt, noncurrent portion 24,266 24,231 24,198 14,853 6,440 9,033 11,630 14,226 12,833 11,836 13,319 14,801 16,286 16,126 7,152 8,705 10,262 11,821
Related party contract liability, noncurrent portion 12,273 12,273 12,273 12,273 12,273 12,273 12,273 12,273 12,273 12,273 12,273 12,273 12,273
Deferred tax liabilities 3,609 3,609 9,647 10,421
Long-term income tax liability 2,969 1,526
Other liabilities 7,659 9,307 9,307 9,307
Noncurrent liabilities 799,656 793,681 794,511 89,472 70,562 71,399 65,658 45,870 53,667 52,224 38,438 32,017 31,322 20,807 22,486 24,189 24,203 15,277 10,248 11,994 13,737
Total liabilities 891,990 897,886 872,714 169,692 212,560 134,773 119,879 112,077 104,697 103,852 78,704 68,012 64,816 46,388 43,611 41,930 42,966 39,285 29,639 27,394 28,353
Preferred stock
Common stock 38 37 37 37 37 36 36 36 36 35 35 35 35 35 34 34 32 31 28 28 28
Additional paid-in capital 586,017 557,882 535,197 586,092 568,705 548,960 535,230 519,096 507,092 494,806 486,014 476,001 471,477 469,283 464,812 460,235 374,386 370,561 271,394 269,582 268,822
Accumulated other comprehensive income (loss) (109) 293 (149) (391) (367) (867) (1,612) (1,337) (1,017) (202) (7) 10 16 9 21 103 35 57 75
Retained earnings (accumulated deficit) 165,811 110,465 66,160 31,174 2,312 (36,813) (177,724) (212,727) (238,288) (252,809) (265,751) (267,699) (267,274) (243,673) (227,799) (214,867) (196,749) (177,974) (163,229) (150,272) (139,664)
Stockholders’ equity 751,757 668,677 601,245 616,912 570,687 511,316 355,930 305,068 267,823 241,830 220,291 208,347 204,254 225,654 237,047 245,423 177,772 192,653 108,250 119,413 129,186
Total liabilities and stockholders’ equity 1,643,747 1,566,563 1,473,959 786,604 783,247 646,089 475,809 417,145 372,520 345,682 298,995 276,359 269,070 272,042 280,658 287,353 220,738 231,938 137,889 146,807 157,539

Based on: 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Shockwave Medical Inc. current liabilities increased from Q3 2023 to Q4 2023 but then slightly decreased from Q4 2023 to Q1 2024.
Noncurrent liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Shockwave Medical Inc. noncurrent liabilities decreased from Q3 2023 to Q4 2023 but then increased from Q4 2023 to Q1 2024 exceeding Q3 2023 level.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Shockwave Medical Inc. total liabilities increased from Q3 2023 to Q4 2023 but then slightly decreased from Q4 2023 to Q1 2024.
Stockholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Shockwave Medical Inc. stockholders’ equity increased from Q3 2023 to Q4 2023 and from Q4 2023 to Q1 2024.